The University of Melbourne
The role involves leading research and method development in structural biology and protein crystallisation at the Bio21 Molecular Science and Biotechnology Institute. It focuses on managing crystallisation facilities, providing scientific advice, fostering collaborations, and supporting innovation in cancer drug discovery.
N/A
The homecoming of a global tech entrepreneur to University of Melbourne
Jul 2, 2025
Trust, attitudes and use of artificial intelligence: A global study 2025
Apr 28, 2025
QS Sustainability Rankings 2026 showcase University of Melbourne’s commitment to sustainability
Nov 19, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The University of Melbourne.
Livium explores microwave technology for REE extraction
Sep 9, 2025
Advisor - Protein Engineering and CAR Design
Eli Lilly and Company
Sr Director, Protein Biochemistry and Lab Automation
Gilead Sciences
Senior Scientist, Stuctural Biology
Altos Labs
Research Assistant
Nanyang Technological University
Postdoctoral Research Fellow - Fischer Lab
Dana-Farber Cancer Institute
Pharma Protein Expression Biochemist
Cogent Scientific